Go to content oder Go to navigation

Collaboration Partners

Many of PharMetrX's Research+ PhD projects are embedded in research collaborations such that our PhD students closely collaborate with experts in pure and applied research as well as clinical applications.


Current research collaboration partners

include:

  • Andrea Weiße (School of Biological Sciences & School of Informatics, University of Edinburgh/UK)
  • Anja Theloe (Charité - Universitätsmedizin Berlin, Dept. Pharmacy)
  • Annette Künkele (Charité - Universitätsmedizin Berlin)
  • Caspar Steenholdt (Herlev Hospital/DK)
  • Christoph Stein (Charité – Universitätsmedizin Berlin)
  • Daniel Hertz (College of Pharmacy, University of Michigan/USA)
  • Gerd Mikus (Heidelberg University Hospital, Dept. of Clinical Pharmacology and Pharmacoepidemiology)
  • Georg Hempel (Clinical Pharmacy, University of Muenster)
  • Gerald Illerhaus (Klinik für Hämatologie, Onkologie und Palliativmedizin, Klinikum Stuttgart)
  • Hermann Wrigge (Integrated Research and Treatment Center Adipositi Diseases, University of Leipzig)
  • Jason Roberts (University of Queensland/AU)
  • Johannes Zander (Laboratory Dr. Brunner, Konstanz)
  • Julio Duarte (University of Florida, College of Pharmacy, Orlando, FL/USA)
  • Larisa Cavallari (University of Florida, College of Pharmacy, Orlando, FL/USA)
  • Lothar Müller (Onkologie UnterEms, Leer)
  • Mark A. Ainsworth (Dept. Gastroenterology, Odense University Hospital/DK)
  • Markus Jörger (Cantonal Hospital St. Gallen/CH)
  • Markus Zeitlinger (Medical University of Vienna/A)
  • Matthias Schwab (Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (IKP), Stuttgart)
  • Mette Julsgaard Nielsen (Dept. Hepatology and Gastroenterology, Aarhus University Hospital/DK)
  • Michael Zoller & Uwe Liebchen (University Hospital, LMU Munich - Campus Großhadern, Dept. of Anaesthesiology)
  • Miriam Stegemann, Frieder Pfäfflin, Ulrike Trost (Charité – Universitätsmedizin Berlin, Dept. of Infectious Diseases and Respiratory Medicine / Antimicrobial Stewardship)
  • Nicole Reisch (University Hospital, LMU Munich - Campus downtown, Dept. of Internal Medicine IV - Endocrinology)
  • Niko Beerenwinkel (ETH Zürich, DBSE Basel/CH)
  • Oliver Scherf-Clavel (Institute of Pharmacy and Food Chemistry, Julius-Maximilians-Universität Würzburg)
  • Peter Hindmarsh (University College London/UK)
  • Philipp Gödel (University Hospital, Cologne)
  • Richard Ross & Martin Whitaker (University of Sheffield & Diurnal, Cardiff/UK)
  • SAKK - Swiss Group for Clinical Cancer Research (Bern/CH)
  • Salim Seyfried, Claudia Rödel und Nastasja Grdseloff (University of Potsdam, Research Group Animal Physiology)
  • Stefan Holdenrieder (German Heart Centre Munich)
  • Stefanie Hennig (Queensland University of Technology, Faculty of Health, School of Clinical Sciences, Brisbane, QLD/AU and Certara Inc., Princeton, New Jersey/USA)
  • Stephan Schmidt (University of Florida, College of Pharmacy, Dept. of Pharmaceutics, Orlando, FL/USA)
  • Torsten Semmler (Robert-Koch-Institut (RKI), Berlin)
  • Ulrich Jaehde (Institute of Pharmacy, University of Bonn)
  • Uta Neumann & Oliver Blankenstein (Charité – Universitätsmedizin Berlin, Campus Virchow Klinikum, Institute for Experimental Paediatric Endocrinology)
  • Walter Reinisch (Medical University of Vienna/A)

Collaboration partners of finished research projects

  • Cassian Yee & Sattva S. Neelapu (The University of Texas MD Anderson Cancer Center, Houston, Texas/USA)